Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | MMP8 | P22894 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 2/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22750873 | 0.78 | SMN1; SMN2 (0.62) | CA9MAPK1ALDH1A1MAPTHTT | |
| SCHEMBL9906199 | 0.74 | MMP1 (0.45) | CA9ALDH1A1MAPTBCHEACHE | |
| SCHEMBL218536 | 0.73 | SMN1; SMN2 (0.68) | CA9MAPK1ALDH1A1MAPTMMP1 | |
| SCHEMBL16367398 | 0.73 | ACHE (0.49) | CA9ALDH1A1MAPTHTTBCHE | |
| SCHEMBL9906204 | 0.73 | MEN1 (0.52) | CA9ALDH1A1MAPTHTTBCHE | |
| SCHEMBL13558102 | 0.72 | MMP1 (0.47) | CA9ALDH1A1MAPTHTTBCHE | |
| SCHEMBL15177296 | 0.72 | SMN1; SMN2 (0.66) | CA9MAPK1ALDH1A1MAPTMMP1 | |
| SCHEMBL8192690 | 0.72 | SMN1; SMN2 (0.66) | CA9MAPK1ALDH1A1MAPTMMP1 | |
| SCHEMBL6801648 | 0.71 | MMP1 (0.61) | ALDH1A1MMP1MMP2MMP9MMP8 | |
| SCHEMBL4401411 | 0.71 | MAPT (0.58) | CA9MAPK1ALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6022966-A | CONJUGATE COMPRISES A DOTA CHELATE COMPONENT, A BIOTIN COMPONENT AND A LINKER COMPONENT RESISTANT TO BIOTINIDASE CLEAVAGE | NEORX CORPORATION (US) | 2000-02-08 | — | — | US | disclosed |
| EP-0736035-A4 | PRETARGETING METHODS AND COMPOUNDS | NEORX CORP (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5847121-A | Production of nitro-benzyl-dota via direct peptide cyclization | NEORX CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0736035-A1 | PRETARGETING METHODS AND COMPOUNDS | NEORX CORPORATION (US) | 1996-10-09 | — | — | EP | disclosed |
| US-5541287-A | DIAGNOSIS USING CYCLIC TRIPEPTIDES WITH NITROBENZYL 1,4,7,10-TETRAAZACYCLODODECANE-N,N*,N**,N***TETRAACETIC ACID BIOTIN CONJUGATE FORMED BY ALKYLATION AND MULTISTAGE PROCESS | NEORX CORPORATION (US) | 1996-07-30 | — | — | US | disclosed |
| WO-1995015335-A2 | PRETARGETING METHODS AND COMPOUNDS | NEORX CORPORATION (US) | 1995-06-08 | — | — | WO | disclosed |